187 related articles for article (PubMed ID: 37026527)
1. Establishment and characterization of a novel cancer stem-like cell of cholangiocarcinoma.
Panawan O; Silsirivanit A; Chang CH; Putthisen S; Boonnate P; Yokota T; Nishisyama-Ikeda Y; Detarya M; Sawanyawisuth K; Kaewkong W; Muisuk K; Luang S; Vaeteewoottacharn K; Kariya R; Yano H; Komohara Y; Ohta K; Okada S; Wongkham S; Araki N
Cancer Sci; 2023 Aug; 114(8):3230-3246. PubMed ID: 37026527
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma.
Raggi C; Taddei ML; Sacco E; Navari N; Correnti M; Piombanti B; Pastore M; Campani C; Pranzini E; Iorio J; Lori G; Lottini T; Peano C; Cibella J; Lewinska M; Andersen JB; di Tommaso L; Viganò L; Di Maira G; Madiai S; Ramazzotti M; Orlandi I; Arcangeli A; Chiarugi P; Marra F
J Hepatol; 2021 Jun; 74(6):1373-1385. PubMed ID: 33484774
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity.
Uthaisar K; Vaeteewoottacharn K; Seubwai W; Talabnin C; Sawanyawisuth K; Obchoei S; Kraiklang R; Okada S; Wongkham S
Oncol Rep; 2016 Sep; 36(3):1435-46. PubMed ID: 27461717
[TBL] [Abstract][Full Text] [Related]
4. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.
Yothaisong S; Dokduang H; Techasen A; Namwat N; Yongvanit P; Bhudhisawasdi V; Puapairoj A; Riggins GJ; Loilome W
Tumour Biol; 2013 Dec; 34(6):3637-48. PubMed ID: 23832540
[TBL] [Abstract][Full Text] [Related]
5. Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.
Raggi C; Correnti M; Sica A; Andersen JB; Cardinale V; Alvaro D; Chiorino G; Forti E; Glaser S; Alpini G; Destro A; Sozio F; Di Tommaso L; Roncalli M; Banales JM; Coulouarn C; Bujanda L; Torzilli G; Invernizzi P
J Hepatol; 2017 Jan; 66(1):102-115. PubMed ID: 27593106
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines.
Dokduang H; Jamnongkarn W; Promraksa B; Suksawat M; Padthaisong S; Thanee M; Phetcharaburanin J; Namwat N; Sangkhamanon S; Titapun A; Khuntikeo N; Klanrit P; Loilome W
Drug Des Devel Ther; 2020; 14():2319-2334. PubMed ID: 32606601
[TBL] [Abstract][Full Text] [Related]
7. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.
Armartmuntree N; Murata M; Techasen A; Yongvanit P; Loilome W; Namwat N; Pairojkul C; Sakonsinsiri C; Pinlaor S; Thanan R
Redox Biol; 2018 Apr; 14():637-644. PubMed ID: 29169115
[TBL] [Abstract][Full Text] [Related]
8. High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy.
Quintavalle C; Burmeister K; Piscuoglio S; Quagliata L; Karamitopoulou E; Sepe R; Fusco A; Terracciano LM; Andersen JB; Pallante P; Matter MS
Mol Carcinog; 2017 Sep; 56(9):2146-2157. PubMed ID: 28467612
[TBL] [Abstract][Full Text] [Related]
9. The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.
Correnti M; Cappon A; Pastore M; Piombanti B; Lori G; Oliveira DVPN; Munoz-Garrido P; Lewinska M; Andersen JB; Coulouarn C; Sulpice L; Peraldo Neia C; Cavalloni G; Quarta S; Biasiolo A; Fassan M; Ramazzotti M; Parri M; Recalcati S; di Tommaso L; Campani C; Invernizzi P; Torzilli G; Marra F; Pontisso P; Raggi C
Liver Int; 2022 Jan; 42(1):233-248. PubMed ID: 34478594
[TBL] [Abstract][Full Text] [Related]
10. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
Qiu G; Ma D; Li F; Sun D; Zeng Z
Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
[TBL] [Abstract][Full Text] [Related]
11. Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.
Tepsiri N; Chaturat L; Sripa B; Namwat W; Wongkham S; Bhudhisawasdi V; Tassaneeyakul W
World J Gastroenterol; 2005 May; 11(18):2748-53. PubMed ID: 15884115
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.
Padthaisong S; Thanee M; Namwat N; Phetcharaburanin J; Klanrit P; Khuntikeo N; Titapun A; Sungkhamanon S; Saya H; Loilome W
J Transl Med; 2020 Feb; 18(1):64. PubMed ID: 32039729
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells.
Raggi C; Gammella E; Correnti M; Buratti P; Forti E; Andersen JB; Alpini G; Glaser S; Alvaro D; Invernizzi P; Cairo G; Recalcati S
Sci Rep; 2017 Dec; 7(1):17667. PubMed ID: 29247214
[TBL] [Abstract][Full Text] [Related]
14. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L
Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588
[TBL] [Abstract][Full Text] [Related]
15. Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells.
Saentaweesuk W; Araki N; Vaeteewoottacharn K; Silsirivanit A; Seubwai W; Talabnin C; Muisuk K; Sripa B; Wongkham S; Okada S; Wongkham C
Oncol Res; 2018 May; 26(4):605-616. PubMed ID: 28762325
[TBL] [Abstract][Full Text] [Related]
16. The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma.
Puthdee N; Sriswasdi S; Pisitkun T; Ratanasirintrawoot S; Israsena N; Tangkijvanich P
Cancer Gene Ther; 2022 May; 29(5):445-455. PubMed ID: 34548635
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Insulin Receptor Substrate 1 (IRS1) Relates to Poor Prognosis and Promotes Proliferation, Stemness, Migration, and Oxidative Stress Resistance in Cholangiocarcinoma.
Kaewlert W; Sakonsinsiri C; Lert-Itthiporn W; Ungarreevittaya P; Pairojkul C; Pinlaor S; Murata M; Thanan R
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768755
[TBL] [Abstract][Full Text] [Related]
18. The Effect of the EGFR - Targeting Compound 3-[(4-Phenylpyrimidin-2-yl) Amino] Benzene-1-Sulfonamide (13f) against Cholangiocarcinoma Cell Lines.
Samatiwat P; Tabtimmai L; Suphakun P; Jiwacharoenchai N; Toviwek B; Kukongviriyapan V; Gleeson MP; Choowongkomon K
Asian Pac J Cancer Prev; 2021 Feb; 22(2):381-390. PubMed ID: 33639651
[TBL] [Abstract][Full Text] [Related]
19. Lactic acidosis promotes aggressive features of cholangiocarcinoma cells via upregulating ALDH1A3 expression through EGFR axis.
Thamrongwaranggoon U; Detarya M; Seubwai W; Saengboonmee C; Hino S; Koga T; Nakao M; Wongkham S
Life Sci; 2022 Aug; 302():120648. PubMed ID: 35598658
[TBL] [Abstract][Full Text] [Related]
20. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]